Binary Sign in Anderson-Fabry Cardiomyopathy

Journal of the American College of Cardiology

Volumn 53, Issue 9, 2009, Pages 813-814

  Pieroni, Maurizio ^a   Crea, Filippo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSPHINGOLIPID;

ANDERSON FABRY CARDIOMYOPATHY; CARDIOMYOPATHY; CLINICAL ASSESSMENT; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; ENZYME REPLACEMENT; FALSE POSITIVE RESULT; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENETIC ANALYSIS; GOLD STANDARD; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BIOPSY; HUMAN; HYPERTENSION; LETTER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; DIAGNOSIS, DIFFERENTIAL; ENDOCARDIUM; FABRY DISEASE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR;

EID: 60449112801     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.07.074     Document Type: Letter

References (4)

1. Kounas S., Demetrescu C., Pantazis A.A., et al. The binary endocardial appearance is a poor discriminator of Anderson-Fabry disease from familial hypertrophic cardiomyopathy. J Am Coll Cardiol 51 (2008) 2058-2061
2. Pieroni M., Chimenti C., De Cobelli F., et al. Fabry's disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization. J Am Coll Cardiol 47 (2006) 1663-1671
3. Wilcox W.R., Oliveira J.P., Hopkin R.J., et al. Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab 93 (2008) 112-128
4. Beer M., Weidemann F., Breunig F., et al. Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy. Am J Cardiol 97 (2006) 1515-1518